Navigation Links
Chemo Pills Effective, But Patients May Skip Doses
Date:1/17/2013

THURSDAY, Jan. 17 (HealthDay News) -- Although chemotherapy pills are able to target certain cancers better than traditional intravenous drugs, some patients have trouble taking them, according to new research.

A study from researchers at Michigan State University found that more than 40 percent of patients took the wrong number of pills or skipped doses altogether. They noted severe side effects and complicated instructions for some oral prescriptions often are to blame.

"Prescriptions for some oral pills have complex instructions," study leader Sandra Spoelstra, an assistant professor of nursing, said in a university news release. "Some of them require patients to take pills several times a day or cycle their doses, taking one pill a day for three weeks, then stopping for a week before starting again. And some patients take two types of pills to treat their cancer or have multiple medications for other chronic conditions. It can be very complicated."

The researchers noted that chemotherapy pills often cause pain, severe nausea, vomiting, diarrhea, fatigue and skin reactions. Patients may skip doses of their medications to avoid these negative side effects, making the pills ineffective.

In the study, which was published recently in the journal Cancer Nursing, the researchers divided the participants into three groups. The first group included patients who had help deciphering their prescriptions from an automated calling system developed at the university. Patients in the second group received the automated calls as well as follow-up calls from nurses providing them with tips on how to stick to their treatment plan. The third group received the automated calls and the follow-up tips from nurses, as well as advice on how to manage their symptoms.

The study found that patients in all three groups said their symptoms had eased by the end of the study. The researchers noted that the automated calls alone were just as effective as when they were offered with tips from nurses.

The study's authors concluded that the automated call system could be an inexpensive way to help patients on chemotherapy pills follow through on their treatment plan correctly. They said nurses should carefully explain oral chemotherapy instructions. The researchers added that their findings could provide a foundation for more research to help improve oral chemotherapy.

"It's cutting-edge treatment, but we don't know enough about it yet," said the study's co-author, Barbara Given, associate dean for research in the university's College of Nursing. "People think if they had a life-threatening disease and their doctor recommended treatment, they'd follow the recommendations. But it's really not that simple."

More information

The U.S. National Cancer Institute provides more information on cancer drugs.

-- Mary Elizabeth Dallas

SOURCE: Michigan State University, news release, Jan. 10, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New model may help predict response to chemotherapy for colorectal cancer
2. Paired CT scans catch chemo-killing of liver tumors in real time
3. UAlberta medical researchers discover new potential chemotherapy
4. Intensified chemotherapy shows promise for children with very high risk form of leukemia
5. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
6. Chemo Brain May Occur Before Treatment Even Starts
7. For Aggressive Breast Cancer, Chemo May Work Better in the Young
8. Immune system kill switch could be target for chemotherapy and infection recovery
9. Chemo May Extend Survival After Breast Cancers Return
10. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
11. Improving chemotherapy effectiveness by acting on the immune system
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo Pills Effective, But Patients May Skip Doses
(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... ... 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce a ... solid foundation. As experts in dangerous situations the Inflow IQ team can help ... deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... 2017 The global reprocessed ... the top five players accounting for nearly 94% ... are Stryker Sustainability Solutions, Ethicon (Johnson & Johnson), ... VANGUARD AG. Despite the high level of consolidation, ... the prevalence of fierce competition among the key ...
(Date:3/23/2017)... -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) today ... Phase 1 study of MM-310 in solid tumors. MM-310 ... taxane and targets the EphA2 receptor, a protein which ... tumor types, including prostate, ovarian, bladder, gastric, pancreatic and ... is an important step in evaluating MM-310,s safety and ...
Breaking Medicine Technology: